Koyfin Home > Directory > Health Care > Portola Pharma > Price / Earnings (ltm)

Portola Pharma Price / Earnings (ltm) Chart (PTLA)

Portola Pharma annual/quarterly Price / Earnings (ltm) from 2013 to 2013. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Portola Pharma Price / Earnings (ltm) for the quarter ending August 08, 2013 was 96.49 a -0.31% decrease of -0.29 year over year
  • Portola Pharma Price / Earnings (ltm) for the last 12 months ending August 08, 2013 was 96.49 a -0.31% decrease of -0.29 year over year
  • Portola Pharma Annual Price / Earnings (ltm) for 2013 was 96.49 a 0.57% increase of 0.55 from 2012
  • Portola Pharma Annual Price / Earnings (ltm) for 2013 was 95.95 a -1.97% decrease of -1.89 from 2012
  • Portola Pharma Annual Price / Earnings (ltm) for 2013 was 97.84 a 1.08% increase of 1.05 from 2012
Other Valuation Metrics:
  • Portola Pharma Market Cap for the quarter ending March 03, 2018 was $2,136m a -49.96% decrease of -1,067m year over year
  • Portola Pharma Price / Book for the quarter ending March 03, 2018 was 6.15 a -222.27% decrease of -13.67 year over year
  • Portola Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,780m a -67.70% decrease of -1,205m year over year
View Chart On Koyfin

Quarterly PTLA Price / Earnings (ltm) Data

08/201396.49
08/201395.95
08/201397.84
08/201396.79
08/201397.63
08/201396.41
08/201399.61
08/2013100.83
08/201397.29
07/201396.70

Annual PTLA Price / Earnings (ltm) Data

201396.49
201395.95
201397.84
201396.79
201397.63
201396.41
201399.61
2013100.83
201397.29
201396.70